Skip to main content
Rheumatology
ALL Specialities
ALL Specialities
/
Rheumatology
Diseases & Conditions
Ankylosing Spondylitis
Gout
Lupus & CTDs
Orthopedics
Osteoarthritis
Osteoporosis
Pain
Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
MD-IQ
RA
Business of Medicine
Coronavirus Updates
News
Misclassifying Spondyloarthritis: MRI Held Risky
Publish date:
January 1, 2010
PDF Download
70023_fx2.sml
DR. GAYLI
Pages
« first
1
2
Recommended Reading
PPIs Seem Safe to Use With Antiplatelet Drugs
MDedge Rheumatology
Heart Disease Down in RA, Heart Failure Rates High
MDedge Rheumatology
Abatacept Shown Effective to Be for RA in Review
MDedge Rheumatology
Septic Arthritis Rates Rose With Anti-TNF Therapy
MDedge Rheumatology
Cochrane: Rituximab Is the Most Effective Biologic for RA
MDedge Rheumatology
Doubts Cast on Tight Link Between RA and Carotid Disease
MDedge Rheumatology
Golimumab Reversed Joint Damage in PsA
MDedge Rheumatology
Was Rofecoxib CV Risk Evident in 2001?
MDedge Rheumatology
Arthritis Capsules
MDedge Rheumatology
Biologics and Pregnancy: Insights From the OTIS Study
MDedge Rheumatology
Rheumatoid Arthritis
All Specialties
